In a landmark decision, the Union Health Ministry has officially banned pharmaceutical sales representatives from visiting doctors inside government hospitals during duty hours. This directive applies to all central and state-run public hospitals across India.Why this ban?To curb the growing commercial influence on medical prescriptions and protect ethical healthcare practices. The new policy ensures that all communication from pharma companies must go through official channels like hospital procurement committees — promoting transparency and patient-first care.Key Highlights:Ban on medical reps inside government hospitalsDoctors cannot meet sales reps during duty hoursPharma companies to use official hospital channelsHospitals must enforce the ban strictlyDisciplinary action for violationsThis move is expected to reduce prescription bias, improve public healthcare transparency, and rebuild trust in India’s medical system.Subscribe for more healthcare updates and policy changes in India.Youtube : https://youtube.com/shorts/_q-5qfY-_xw?feature=shareWEBSITE : https://medgatetoday.com/

Ver todos los episodios